By decreasing the stability and expression of ASS1 mRNA, circRAPGEF1 reprograms aspartate metabolism, thereby activating the S6K/CAD signaling pathway, enhancing HCC cell stemness properties and proliferation. Here, CAD is linked to hepatocellular carcinoma.